Tiemann2011_PhenotypeTransitions

  public model
Short description

To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.

In summary, you are entitled to use this encoded model in absolutely any manner you deem suitable, verbatim, or with modification, alone or embedded it in a larger context, redistribute it, commercially or not, in a restricted way or not.

To cite BioModels Database, please use: Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Novère N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.

Format
SBML (L2V4)
Related Publication
  • Parameter adaptations during phenotype transitions in progressive diseases.
  • Tiemann CA, Vanlier J, Hilbers PA, van Riel NA
  • BMC systems biology , 10/ 2011 , Volume 5 , pages: 174
  • Department of BioMedical Engineering, Eindhoven University of Technology, Den Dolech 2, Eindhoven, 5612 AZ, The Netherlands. c.a.tiemann@tue.nl
  • The study of phenotype transitions is important to understand progressive diseases, e.g., diabetes mellitus, metabolic syndrome, and cardiovascular diseases. A challenge remains to explain phenotype transitions in terms of adaptations in molecular components and interactions in underlying biological systems.Here, mathematical modeling is used to describe the different phenotypes by integrating experimental data on metabolic pools and fluxes. Subsequently, trajectories of parameter adaptations are identified that are essential for the phenotypical changes. These changes in parameters reflect progressive adaptations at the transcriptome and proteome level, which occur at larger timescales. The approach was employed to study the metabolic processes underlying liver X receptor induced hepatic steatosis. Model analysis predicts which molecular processes adapt in time after pharmacological activation of the liver X receptor. Our results show that hepatic triglyceride fluxes are increased and triglycerides are especially stored in cytosolic fractions, rather than in endoplasmic reticulum fractions. Furthermore, the model reveals several possible scenarios for adaptations in cholesterol metabolism. According to the analysis, the additional quantification of one cholesterol flux is sufficient to exclude many of these hypotheses.We propose a generic computational approach to analyze biological systems evolving through various phenotypes and to predict which molecular processes are responsible for the transition. For the case of liver X receptor induced hepatic steatosis the novel approach yields information about the redistribution of fluxes and pools of triglycerides and cholesterols that was not directly apparent from the experimental data. Model analysis provides guidance which specific molecular processes to study in more detail to obtain further understanding of the underlying biological system.
Contributors
Natal van Riel

Metadata information

is
BioModels Database MODEL1112150000
isDescribedBy
PubMed 22029623
hasTaxon
Taxonomy Mus musculus
isVersionOf
Gene Ontology glucose homeostasis
Human Disease Ontology fatty liver disease
Curation status
Curated
  • Model originally submitted by : Natal van Riel
  • Submitted: Dec 15, 2011 7:57:03 PM
  • Last Modified: Aug 14, 2017 4:28:26 PM
Revisions
  • Version: 2 public model Download this version
    • Submitted on: Aug 14, 2017 4:28:26 PM
    • Submitted by: Natal van Riel
    • With comment: Current version of Tiemann2011_PhenotypeTransitions
  • Version: 1 public model Download this version
    • Submitted on: Dec 15, 2011 7:57:03 PM
    • Submitted by: Natal van Riel
    • With comment: Original import of hepatic lipid and plasma lipoprotein metabolism